You are here

How to treat CML in 2017?

How to treat CML in 2017?

Andreas Hochhaus, Universitätsklinikum Jena, Germany  

  • Objectives of treatment optimization
  • Choice of initial therapy
  • Clinical data on 1st and 2nd generation TKI's
  • Comorbidities in CML at diagnosis
  • Main adverse events of TKI's
  • ELN recommendations for monitoring of first-line TKI therapy
  • Recommendations for switch: CP-CML
  • Management of blast crisis
  • Limitations of TKI therapies
  • Discussion: are we ready for routine stopping procedure?
  • Recommendations on CML management 2013 - 2017

 This presentation is adapted from the one presented during the CML educational session at EHA. It lasts around 30 minutes.